Skip to content

What are the toxic effects of promethazine?

4 min read

In a study of poisoning admissions, delirium occurred in 42% of patients who overdosed on promethazine alone [1.11.3]. Understanding what are the toxic effects of promethazine is crucial for safe use and recognizing the signs of overdose, which can range from CNS depression to life-threatening conditions [1.3.3].

Quick Summary

Promethazine toxicity manifests primarily as central nervous system depression, respiratory depression, and severe anticholinergic symptoms like delirium. Severe cases can lead to seizures, cardiac issues, and neuroleptic malignant syndrome.

Key Points

  • CNS Depression is a Primary Effect: Promethazine toxicity commonly causes severe drowsiness, confusion, delirium, and potentially coma [1.3.3, 1.2.1].

  • Respiratory Depression is a Boxed Warning: The medication can cause fatal respiratory depression, especially in children under two years old, for whom it is contraindicated [1.7.3, 1.3.3].

  • Neuroleptic Malignant Syndrome (NMS): A rare but life-threatening reaction characterized by high fever, muscle rigidity, and altered mental status can occur [1.5.1].

  • Risk of Severe Tissue Injury: Injectable promethazine has a boxed warning for causing severe tissue damage, necrosis, and even gangrene upon incorrect administration [1.8.1, 1.4.2].

  • Cardiovascular Risks Exist: Overdose can lead to hypotension (low blood pressure) and cardiac arrhythmias, including QTc interval prolongation [1.2.3, 1.6.2].

  • Extrapyramidal Symptoms: The drug can cause movement disorders like involuntary muscle spasms (dystonia), restlessness (akathisia), and tremors [1.2.3].

  • No Specific Antidote: Treatment for promethazine overdose is supportive and focuses on managing symptoms like respiratory failure, seizures, and hypotension [1.9.2].

In This Article

Understanding Promethazine and Its Toxicity

Promethazine is a first-generation antihistamine belonging to the phenothiazine family of medications [1.2.3]. It is commonly used to treat allergies, motion sickness, nausea, and vomiting, and for sedation [1.3.3, 1.4.2]. While effective for these conditions, it carries a significant risk of toxicity, especially in overdose or when used improperly. Its toxic effects stem from its actions as a strong anticholinergic agent and its impact on various receptors in the central nervous system (CNS) [1.2.3]. An overdose can lead to a wide array of symptoms, from severe drowsiness and confusion to life-threatening complications like respiratory depression and cardiac arrhythmias [1.3.3, 1.2.1].

Central Nervous System (CNS) Toxicity

The most prominent toxic effects of promethazine involve the central nervous system.

  • Sedation and Coma: The main feature of promethazine toxicity is CNS depression, which can range from severe drowsiness to a coma where the individual is unresponsive [1.3.3, 1.2.1]. This sedative effect is amplified when combined with other CNS depressants like alcohol, opioids, or benzodiazepines [1.3.3].
  • Delirium and Paradoxical Excitation: While sedation is common, promethazine can also cause paradoxical reactions like agitation, confusion, disorientation, and hallucinations [1.2.1]. Children, in particular, may experience hyperexcitability and nightmares instead of drowsiness [1.3.2, 1.7.3]. A study found that the probability of developing delirium increases with the ingested dose, with a 1-gram dose resulting in a 55% probability [1.11.3].
  • Seizures and Movement Disorders: Overdose can lower the seizure threshold and cause convulsions [1.4.1, 1.2.1]. Promethazine can also induce extrapyramidal symptoms (EPS), which are drug-induced movement disorders. These include acute dystonia (involuntary muscle stiffness and spasms, especially in the neck and face), akathisia (an inability to sit still), and pseudoparkinsonism [1.2.3, 1.2.1]. Involuntary tongue movements and tremors are also signs of nervous system toxicity [1.2.1].

Neuroleptic Malignant Syndrome (NMS)

A rare but potentially fatal toxic effect associated with promethazine is Neuroleptic Malignant Syndrome (NMS) [1.4.2]. NMS is a life-threatening reaction characterized by a combination of symptoms:

  • High fever (hyperpyrexia) [1.5.1]
  • Severe muscle rigidity, sometimes called "lead pipe" rigidity [1.5.1]
  • Altered mental status (confusion, delirium, or coma) [1.5.1]
  • Autonomic instability (irregular pulse, variable blood pressure, excessive sweating) [1.5.1]

NMS requires immediate discontinuation of the drug and intensive medical treatment [1.5.1, 1.9.2].

Respiratory and Cardiovascular Toxicity

Respiratory Depression One of the most dangerous toxic effects of promethazine is severe respiratory depression, which can be fatal [1.7.3]. This risk is so significant that the FDA has issued a boxed warning against its use in children under two years of age [1.3.3, 1.7.3]. Even in children over two, it must be used with extreme caution and at the lowest effective dose, avoiding other respiratory depressant drugs [1.7.3]. Between 1969 and 2003, there were reports of 22 cases of respiratory depression in children under two, seven of which were fatal [1.7.1].

Cardiovascular Effects Promethazine toxicity can also affect the heart.

  • Hypotension: Low blood pressure is a known side effect [1.2.3]. In cases of overdose, severe hypotension may occur, which requires treatment with intravenous fluids and, in some cases, vasopressors like norepinephrine. Epinephrine should not be used as it can paradoxically lower blood pressure further [1.9.1, 1.9.2].
  • Cardiac Arrhythmias: Tachycardia (a rapid heartbeat) is a common finding in overdose [1.2.1]. More seriously, promethazine can prolong the QTc interval, an electrical phase of the heartbeat [1.6.2]. A prolonged QTc interval increases the risk of life-threatening arrhythmias like Torsades de Pointes [1.6.2].

Severe Tissue Injury (Injection)

Injectable promethazine carries a black box warning for the risk of severe tissue injury, including gangrene, regardless of the administration route [1.4.2, 1.8.1]. It is a chemical irritant that can cause serious damage if it is injected into an artery or leaks out of the vein into the surrounding tissue (extravasation) [1.8.2]. Complications can include burning pain, swelling, blistering, nerve damage, tissue necrosis (death), and gangrene, sometimes requiring surgical intervention, skin grafts, or even amputation [1.8.4, 1.8.1]. Because of these risks, intramuscular injection is the preferred route over intravenous administration [1.8.2].

Promethazine vs. Diphenhydramine (Benadryl) Toxicity

Feature Promethazine Diphenhydramine (Benadryl)
Primary Class Phenothiazine Antihistamine [1.2.3] Ethanolamine Antihistamine [1.10.1]
Black Box Warnings Yes: Respiratory depression in children <2; Severe tissue injury with injection [1.4.2] No specific black box warnings mentioned.
Risk of NMS Yes, associated with phenothiazine class [1.4.2] Not typically associated.
Extrapyramidal Symptoms Higher risk due to dopamine D2 receptor antagonism [1.2.3] Lower risk.
Drug Interactions Interacts with a high number of drugs (over 750 known) [1.10.1] Interacts with a high number of drugs (over 450 known) [1.10.1]
Half-Life Longer (around 16 hours for some formulations) [1.10.1] Shorter (around 9.3 hours) [1.10.1]

Management of Promethazine Toxicity

There is no specific antidote for promethazine overdose [1.9.2]. Treatment is primarily symptomatic and supportive [1.9.2].

  1. Airway Support: The first priority is ensuring a patent airway and adequate breathing. In cases of severe CNS or respiratory depression, this may require intubation and mechanical ventilation [1.9.3].
  2. Decontamination: Activated charcoal may be given if the overdose is recent (within about two hours) to help reduce absorption of the drug from the gut [1.9.2].
  3. Cardiovascular Support: Hypotension is managed with IV fluids and repositioning. If vasopressors are needed, norepinephrine is preferred over epinephrine [1.9.1]. Continuous ECG monitoring is used to watch for arrhythmias [1.9.3].
  4. Seizure Control: Seizures may be treated with benzodiazepines like diazepam [1.9.1].
  5. NMS Treatment: If NMS develops, the drug is stopped immediately, and intensive cooling measures are started, along with medications like dantrolene or bromocriptine [1.5.4, 1.9.2].

For authoritative information, please consult resources like the National Institutes of Health (NIH)

Conclusion

The toxic effects of promethazine are extensive and can be severe, particularly in overdose and in vulnerable populations like young children. Major toxicities include profound central nervous system and respiratory depression, life-threatening Neuroleptic Malignant Syndrome, extrapyramidal symptoms, and cardiovascular complications. The injectable form also carries a risk of severe tissue damage. Due to this significant potential for harm, it is essential that promethazine be used only as directed, at the lowest effective dose, and with full awareness of its potential adverse effects and drug interactions.

Frequently Asked Questions

Taking too much promethazine can lead to overdose, with symptoms ranging from severe drowsiness, dizziness, and confusion to more serious effects like respiratory depression (slowed or stopped breathing), seizures, uncontrollable movements, hallucinations, and loss of consciousness [1.3.1, 1.3.2].

Promethazine is not recommended for children under two years of age due to a high risk of potentially fatal respiratory depression [1.7.3]. The FDA has issued a boxed warning for this specific risk [1.3.3].

Yes, in toxic doses, promethazine can cause cardiovascular side effects including rapid heartbeat (tachycardia), low blood pressure (hypotension), and arrhythmias [1.2.3]. It can also prolong the QTc interval, which increases the risk of serious ventricular arrhythmias [1.6.2].

Neuroleptic Malignant Syndrome (NMS) is a rare but life-threatening reaction to medications like promethazine. Its symptoms include high fever, severe muscle rigidity, altered mental status, and autonomic dysfunction (e.g., irregular pulse, sweating) [1.5.1].

Extrapyramidal symptoms (EPS) are movement disorders caused by promethazine's effect on dopamine receptors. They can include tardive dyskinesia (involuntary, repetitive body movements), pseudoparkinsonism, and acute dystonia (muscle spasms and twisting) [1.2.3].

There is no specific antidote. Treatment is supportive and symptomatic, focusing on managing the airway, assisting with breathing if necessary, administering IV fluids for hypotension, and using medications like benzodiazepines to control seizures [1.9.2, 1.9.1].

Injectable promethazine is a vesicant (chemical irritant) that can cause severe tissue injury, including necrosis and gangrene, if administered improperly, such as into an artery or if it leaks from the vein [1.8.1]. This has led to an FDA boxed warning and recommendations to avoid its IV use when possible [1.8.2, 1.4.2].

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.